CSF proteomic signature predicts progression to Alzheimer's disease dementia
CSF proteomic signature predicts progression to Alzheimer's disease dementia
About this item
Full title
Author / Creator
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Introduction
Individuals in the Alzheimer's disease (AD) continuum with mild cognitive impairment (prodromal AD) are at increased risk to develop dementia. Still, underlying pathophysiological processes remain unclear. We studied whether cerebrospinal fluid (CSF) proteome changes are related to time to clinical progression in prodromal AD.
Me...
Alternative Titles
Full title
CSF proteomic signature predicts progression to Alzheimer's disease dementia
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_0ab17a1cfdc049f6b869fea850087572
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0ab17a1cfdc049f6b869fea850087572
Other Identifiers
ISSN
2352-8737
E-ISSN
2352-8737
DOI
10.1002/trc2.12240
